- Home
- Results news
- Continental Chemicals
- Q2 FY27 results
Continental Chemicals Q2 FY27 results: net profit down 8.3% to ₹0.11 crore, revenue up 16.7%
Continental Chemicals Ltd reported standalone revenue of ₹0.07 crore in Q2 FY27, up 16.7% from Q2 FY26. Net profit was ₹0.11 crore, down 8.3%, while basic EPS was ₹0.50; the quarter closed with negative EBITDA of ₹0.24 crore.
Key points
- Q2 FY27 revenue was ₹0.07 crore, up 16.7% from ₹0.06 crore in Q2 FY26.
- EBITDA was a loss of ₹0.24 crore in Q2 FY27 against a loss of ₹0.18 crore a year earlier.
- Net profit was ₹0.11 crore, down 8.3% from ₹0.12 crore in Q2 FY26, and basic EPS was ₹0.50.
- Against Q1 FY27, revenue rose 16.7%, while net profit fell 8.3% and basic EPS fell 2.0%.
- H1 FY27 revenue was ₹0.12 crore, unchanged from H1 FY26, while net profit was ₹0.23 crore.
How did Continental Chemicals perform in Q2 FY27?
Continental Chemicals reported standalone revenue of ₹0.07 crore in Q2 FY27, up 16.7% from ₹0.06 crore in Q2 FY26 and from ₹0.06 crore in Q1 FY27. Total income was ₹0.48 crore, against ₹0.41 crore a year earlier and ₹0.43 crore in the previous quarter. These figures cover the standalone results; no consolidated quarter figures were given.
EBITDA was a loss of ₹0.24 crore in Q2 FY27, compared with a loss of ₹0.18 crore in Q2 FY26 and ₹0.19 crore in Q1 FY27. The EBITDA margin was -366.8%, against -295.0% a year earlier and -336.9% in the previous quarter. Profit before tax was ₹0.14 crore, unchanged from Q2 FY26 and up from ₹0.13 crore in Q1 FY27.
Net profit was ₹0.11 crore in Q2 FY27, down 8.3% from ₹0.12 crore in both Q2 FY26 and Q1 FY27. Basic EPS was ₹0.50, compared with ₹0.51 in each of the two earlier quarters. The board approved the unaudited standalone results and limited review report on 5 November 2026.
| ₹ crore | Q2 FY27 | Q1 FY27 | Q2 FY26 | YoY | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 0.07 | 0.06 | 0.06 | +16.7% | +16.7% |
| Other income | 0.42 | 0.37 | 0.35 | +20.0% | +13.5% |
| Total expenses | 0.34 | 0.30 | 0.27 | +25.9% | +13.3% |
| EBITDA | −0.24 | −0.19 | −0.18 | ||
| EBITDA margin | -366.8% | -336.9% | -295.0% | −71.8 pp | −29.9 pp |
| Profit before tax | 0.14 | 0.13 | 0.14 | +0.0% | +7.7% |
| Tax | 0.03 | 0.01 | 0.03 | +0.0% | +200.0% |
| Net profit | 0.11 | 0.12 | 0.12 | −8.3% | −8.3% |
| EPS (₹) | 0.50 | 0.51 | 0.51 | −2.0% | −2.0% |
EBITDA here is revenue from operations less operating costs (total expenses excluding finance costs and depreciation): before other income and exceptional items. Growth is shown only when both figures are positive. Source: Company's results filing (XBRL).
What changed in Continental Chemicals' costs and profit?
Total expenses were ₹0.34 crore in Q2 FY27, up 25.9% from ₹0.27 crore in Q2 FY26. Other expenses increased by ₹0.08 crore to ₹0.17 crore, while employee cost fell by ₹0.01 crore to ₹0.14 crore. Finance cost was ₹0.01 crore and depreciation was ₹0.02 crore, both unchanged from the year-ago quarter.
Other income rose by ₹0.07 crore to ₹0.42 crore from ₹0.35 crore in Q2 FY26, while total income increased by ₹0.07 crore to ₹0.48 crore. Profit before tax was ₹0.14 crore, unchanged from the year-ago quarter. Tax was ₹0.03 crore, also unchanged, and there was no exceptional item.
Against Q1 FY27, total expenses increased by ₹0.04 crore to ₹0.34 crore. Other expenses rose by ₹0.06 crore to ₹0.17 crore, depreciation fell by ₹0.02 crore to ₹0.02 crore, and other income rose by ₹0.05 crore to ₹0.42 crore. Tax rose by ₹0.02 crore to ₹0.03 crore, and there was no exceptional item.
| ₹ crore | Q2 FY27 | Q2 FY26 | Change | Change % |
|---|---|---|---|---|
| Cost of materials | 0 | 0 | 0 | |
| Employee cost | 0.14 | 0.15 | −0.01 | −6.7% |
| Finance costs | 0.01 | 0.01 | 0 | +0.0% |
| Depreciation | 0.02 | 0.02 | 0 | +0.0% |
| Other expenses | 0.17 | 0.09 | +0.08 | +88.9% |
| Total expenses | 0.34 | 0.27 | +0.07 | +25.9% |
| Other income | 0.42 | 0.35 | +0.07 | +20.0% |
| Tax | 0.03 | 0.03 | 0 | +0.0% |
Source: Company's results filing (XBRL).
How did the first half of FY27 go?
In the first half of FY27, standalone revenue was ₹0.12 crore, unchanged from H1 FY26. Total income rose 11.0% to ₹0.91 crore from ₹0.82 crore, while profit before tax fell 12.9% to ₹0.27 crore from ₹0.31 crore.
H1 FY27 net profit was ₹0.23 crore, down 11.5% from ₹0.26 crore in H1 FY26. Basic EPS declined 12.2% to ₹1.01 from ₹1.15. The filed results showed a single operating segment.
| ₹ crore | H1 FY27 | H1 FY26 | Change |
|---|---|---|---|
| Revenue from operations | 0.12 | 0.12 | +0.0% |
| Profit before tax | 0.27 | 0.31 | −12.9% |
| Net profit | 0.23 | 0.26 | −11.5% |
| EPS (₹) | 1.01 | 1.15 | −12.2% |
Source: Company's results filing (XBRL).
What do the balance sheet and cash flow show?
At 30 September 2026, total assets were ₹7.02 crore, compared with ₹6.64 crore at 31 March 2026. Total equity rose to ₹5.78 crore from ₹5.55 crore, while borrowings remained ₹0.03 crore. Cash increased to ₹0.52 crore from ₹0.02 crore over the same period.
For the first half of FY27, operating cash flow was ₹0.40 crore, compared with ₹0.04 crore in H1 FY26. Investing cash flow was ₹0.12 crore against ₹0.01 crore, while financing cash flow was a cash outflow of ₹0.02 crore in both periods. Capital expenditure was ₹0 crore in each period.
| ₹ crore | As of 30 September 2026 | As of 31 March 2026 |
|---|---|---|
| Total assets | 7.02 | 6.64 |
| Total equity | 5.78 | 5.55 |
| Borrowings | 0.03 | 0.03 |
| Cash and equivalents | 0.52 | 0.02 |
| Inventories | 0 | 0 |
| Trade receivables | 0 | 0 |
Source: Company's results filing (XBRL).
| ₹ crore | H1 FY27 | H1 FY26 |
|---|---|---|
| Cash from operations | 0.40 | 0.04 |
| Cash from investing | 0.12 | 0.01 |
| Cash from financing | −0.02 | −0.02 |
| Capital expenditure | 0 | 0 |
Source: Company's results filing (XBRL).
How has Continental Chemicals done over the last 8 quarters?
Revenue was ₹0.07 crore in Q2 FY27, the higher of the latest quarterly readings and above ₹0.06 crore in Q1 FY27. Net profit was ₹0.11 crore, lower than ₹0.12 crore in the previous quarter, while the EBITDA margin moved from -336.9% to -366.8%.
Across the available quarterly series, net profit was highest at ₹0.20 crore in Q4 FY25 and lowest at ₹0.10 crore in Q3 FY25. The EBITDA margin was highest at -212.8% in Q4 FY25 and lowest at -371.5% in Q3 FY25, before reaching -366.8% in Q2 FY27.
How did other Software Products companies do?
Fifteen other Software Products companies that had filed for the quarter were compared with Continental Chemicals. Their median revenue growth was 6.6%, while 10 grew more slowly than Continental Chemicals and five grew faster.
Ten of the 19 peers whose profit was compared reported higher profit. The peer comparison was available as of 6 November 2026.
| Continental Chemicals revenue growth (YoY) | +16.7% |
|---|---|
| Median of 15 other Software Products companies | +6.6% |
| Companies with slower revenue growth than Continental Chemicals | 10 of 15 |
| Companies with faster revenue growth than Continental Chemicals | 5 of 15 |
| Companies whose net profit rose | 10 of 19 |
Source: Filed results (XBRL) of the industry's companies.
Quick answers
What was Continental Chemicals' revenue in Q2 FY27?
Revenue from operations was ₹0.07 crore, up 16.7% from ₹0.06 crore in Q2 FY26 (standalone).
Did Continental Chemicals make a profit in Q2 FY27?
Yes. Net profit was ₹0.11 crore, against a net profit of ₹0.12 crore in Q2 FY26.
What was Continental Chemicals' EPS in Q2 FY27?
Basic earnings per share were ₹0.50, against ₹0.51 in Q2 FY26.
When did Continental Chemicals announce its Q2 FY27 results?
On 5 November 2026, in a filing to the BSE.
Sources
- Board Meeting Outcome for OUTCOME OF THE BOARD MEETING HELD ON 5TH NOVEMBER, 2026, THURSDAY AT THE REGISTERED OFFICE OF THE COMPANY SITUATED AT A-7, SECTOR-7 , NOIDA-201301 STARTED AT 3:00 PM AND CONCLUDED AT 3:30 PM (BSE, 5 November 2026) · PDF
- QUARTERLY RESULTS FOR SEPTEMBER 2026 (BSE, 5 November 2026) · PDF
How this was written: every figure in the tables and charts is calculated from the company’s filed results (XBRL) and MarketPing’s price measurements. The text is drafted with AI from those figures and the filings, and a checker removes any sentence carrying a number it cannot trace to them. How we write these.
This is information, not investment advice. MarketPing does not recommend buying or selling any security.